StockData
ACRVNasdaqPharmaceutical PreparationsFiscal year ends December 31

Acrivon Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.69+0.05 (+3.05%)

Close on Oct 19, 2026

Market cap
$70.71M
P/E (TTM)
–
Dividend yield
–

SEC filings

40 of Acrivon Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KAug 12, 2026Aug 12, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 12, 2026SEC EDGAR
Current report8-KJun 17, 2026Jun 17, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 13, 2026SEC EDGAR
Current report8-KMay 13, 2026May 13, 2026SEC EDGAR
Proxy statementDEF 14AJun 17, 2026Apr 30, 2026SEC EDGAR
Current report8-KMar 19, 2026Mar 19, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 19, 2026SEC EDGAR
Current report8-KFeb 25, 2026Mar 2, 2026SEC EDGAR
Current report8-KFeb 27, 2026Feb 27, 2026SEC EDGAR
Current report8-KJan 8, 2026Jan 8, 2026SEC EDGAR
Current report8-KJan 8, 2026Jan 8, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 13, 2025SEC EDGAR
Current report8-KNov 13, 2025Nov 13, 2025SEC EDGAR
Current report8-KSep 5, 2025Sep 5, 2025SEC EDGAR
Current report8-KAug 13, 2025Aug 13, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 13, 2025SEC EDGAR
Current report8-KJun 13, 2025Jun 13, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 14, 2025SEC EDGAR
Current report8-KMay 14, 2025May 14, 2025SEC EDGAR
Proxy statementDEF 14AJun 13, 2025Apr 25, 2025SEC EDGAR
Current report8-KApr 7, 2025Apr 7, 2025SEC EDGAR
Current report8-KMar 27, 2025Mar 27, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 27, 2025SEC EDGAR
Current report8-KMar 25, 2025Mar 25, 2025SEC EDGAR
Current report8-KMar 11, 2025Mar 14, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 13, 2024SEC EDGAR
Current report8-KNov 13, 2024Nov 13, 2024SEC EDGAR
Current report8-KOct 11, 2024Oct 11, 2024SEC EDGAR
Current report8-KSep 14, 2024Sep 16, 2024SEC EDGAR
Current report8-KAug 13, 2024Aug 13, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 13, 2024SEC EDGAR
Current report8-KJun 20, 2024Jun 21, 2024SEC EDGAR
Current report8-KMay 14, 2024May 14, 2024SEC EDGAR
Quarterly report10-QMar 31, 2024May 14, 2024SEC EDGAR
Proxy statementDEF 14AJun 20, 2024Apr 26, 2024SEC EDGAR
Current report8-KApr 24, 2024Apr 24, 2024SEC EDGAR
Current report8-KApr 8, 2024Apr 9, 2024SEC EDGAR
Current report8-KMar 28, 2024Mar 28, 2024SEC EDGAR
Annual report10-KDec 31, 2023Mar 28, 2024SEC EDGAR